Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

NCT00126308 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

100

Enrollment

OTHER_GOV

Sponsor class

Stopped no change in primary endpoint at week 48

Conditions

HIV-Associated Lipodystrophy
HIV Infections

Interventions

DEVICE: poly-L-lactic acid
DEVICE: poly-L-lactic acid

Sponsor

Kirby Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]